160
Participants
Start Date
May 1, 2024
Primary Completion Date
December 25, 2025
Study Completion Date
April 30, 2026
Dimenhydrinate
Dimenhydrinate 50mg intravenously
Preeyaporn Jirakittidul
OTHER